|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.58 USD | -2.44% |
|
+1.40% | -4.85% |
| 30/07 | Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval | DJ |
| 29/07 | Pfizer Inc. and Biontech Se Receive European Commission Authorization for 2026-2027 Xfg-Adapted Covid-19 Vaccine | CI |
| Market Cap | 19.91B 22.91B 18.53B 17.02B 32.13B 2,187B 32.63B 218B 85.74B 1,089B 86.03B 84.14B 3,650B | P/E 2026 * |
-17.9x | P/E 2027 * | -17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 9.06B 10.42B 8.44B 7.74B 14.62B 995B 14.85B 99.43B 39.02B 495B 39.15B 38.29B 1,661B | EV / Sales 2026 * |
4.18x | EV / Sales 2027 * | 4.77x |
| Free-Float |
96.06% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioNTech SE
| 1 day | -2.44% | ||
| 1 week | +1.40% | ||
| 1 month | -2.65% | ||
| 3 months | -12.44% | ||
| 6 months | -20.37% | ||
| Current year | -4.85% |
| 1 week | 88.5 | 94.38 | |
| 1 month | 88.35 | 98.81 | |
| Current year | 79.52 | 124 | |
| 1 year | 79.52 | 124 | |
| 3 years | 76.53 | 131.49 | |
| 5 years | 76.53 | 464 | |
| 10 years | 12.52 | 464 |
| Manager | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/2018 |
Ugur Sahin
CEO | Chief Executive Officer | 60 | 02/06/2008 |
| Director of Finance/CFO | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 55 | 02/06/2008 |
| Director/Board Member | 69 | 02/06/2008 | |
| Director/Board Member | 65 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/3/26 | Other | Director | 1,927 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | ||
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | ||
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | ||
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | ||
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | ||
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | ||
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | ||
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | ||
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | ||
| -3.06% | -1.11% | +435.76% | +145.22% | 11.92B | ||
| Average | -0.42% | -3.52% | +74.61% | +156.14% | 24.58B | |
| Weighted average by Cap. | +0.07% | -2.87% | +48.42% | +121.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.17B 2.49B 2.02B 1.85B 3.5B 238B 3.55B 23.79B 9.34B 119B 9.37B 9.16B 397B | 2.23B 2.57B 2.08B 1.91B 3.6B 245B 3.66B 24.48B 9.61B 122B 9.64B 9.43B 409B |
| Net income | -1.04B -1.2B -972M -892M -1.69B -115B -1.71B -11.46B -4.5B -57.09B -4.51B -4.41B -191B | -1.16B -1.34B -1.08B -995M -1.88B -128B -1.91B -12.78B -5.01B -63.67B -5.03B -4.92B -213B |
| Net Debt | -10.85B -12.48B -10.1B -9.27B -17.51B -1,191B -17.78B -119B -46.72B -593B -46.88B -45.85B -1,989B | -9.28B -10.68B -8.64B -7.93B -14.98B -1,019B -15.21B -102B -39.97B -507B -40.1B -39.22B -1,701B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | USD 90.58 | -2.44% | 710,906 |
| 30/07/26 | USD 92.85 | -0.11% | 1,381,280 |
| 29/07/26 | USD 92.95 | +0.54% | 740,136 |
| 28/07/26 | USD 92.45 | +1.49% | 679,283 |
| 27/07/26 | USD 91.09 | +1.97% | 687,342 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BNTX Stock
Select your edition
All financial news and data tailored to specific country editions



















